Inergetics (NRTI) 10-K 15 Apr 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Apr. 08, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Registrant Name	INERGETICS INC
Entity Central Index Key	72170
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float	$1,330,803
Trading Symbol	NRTI
Entity Common Stock, Shares Outstanding		218,508,160

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash	$5,762	$106,773
Accounts receivable	342,607	472,297
Receivable from the Technology Business Tax Certificate Transfer Program	375,645	3,357,144
Deferred cost of goods sold	0	569,036
Inventories, net	686,275	420,186
Prepaid expenses	133,486	447,355
Total current assets	1,543,775	5,372,791
Patents and intangible assets, net	147,815	149,391
Goodwill	135,000	135,000
Deposits	101,508	421,191
Total assets	1,928,098	6,078,373
Current liabilities:
Accounts payable and accrued expenses	4,416,724	5,089,488
Deferred revenue	0	1,269,470
Obligations to be settled in stock	553,812	699,085
Derivative liability	910,590	318,000
Short-term debt, net of unamortized debt discount	2,462,528	1,276,358
Short-term debt to affiliates, net of unamortized debt discount	3,829,075	2,843,728
Total current liabilities	12,172,729	11,496,129
Long-term debt	0	103,912
Long-term debt to affiliates	0	1,425,522
Total liabilities	12,172,729	13,025,563
Commitments and contingencies
Preferred stock, par value $1:
Common stock, par value $0.001; authorized 2,000,000,000 shares; issued and outstanding 143,301,039 and 62,461,448 shares, respectively	143,301	62,462
Additional paid-in capital	73,319,330	68,789,021
Accumulated deficit	-92,855,018	-84,737,002
Total stockholders' deficit	-19,327,624	-15,820,756
Total liabilities and stockholders' deficit	1,928,098	6,078,373
Convertible Series B
Current liabilities:
Preferred stock	130,282	130,282
Preferred stock, par value $1:
Total stockholders' deficit	130,282	130,282
Cumulative Series C
Preferred stock, par value $1:
Preferred stock	64,763	64,763
Total stockholders' deficit	64,763	64,763
Convertible Series G
Current liabilities:
Preferred stock	8,952,711	8,743,284
Preferred stock, par value $1:
Total stockholders' deficit	$8,952,711	$8,743,284

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value	$0.00	$0.00
Common stock, authorized	2,000,000,000	2,000,000,000
Common stock, issued	143,301,039	62,461,448
Common stock, outstanding	143,301,039	62,461,448
Convertible Series B
Preferred stock, Convertible Series, par value	$2	$2
Preferred stock, Convertible Series, shares issued	65,141	65,141
Preferred stock, Convertible Series, shares outstanding	65,141	65,141
Cumulative Series C
Preferred stock, par value	$1	$1
Preferred Stock, shares issued	64,763	64,763
Preferred stock, shares outstanding	64,763	64,763
Convertible Series G
Preferred stock, Convertible Series, authorized	400,000	400,000
Preferred stock, Convertible Series, par value	$1	$1
Preferred stock, Convertible Series, stated value	$50	$50
Preferred stock, Convertible Series, shares issued	246,976	198,074
Preferred stock, Convertible Series, shares outstanding	246,976	198,074
Preferred stock, par value	$1

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Net sales	$1,991,688	$847,834
Cost of sales	1,471,334	603,006
Gross profit	520,354	244,828
Research and development costs	23,944	44,090
Selling, general and administrative expenses (including share based compensation of $914,479 and $611,500, respectively)	7,419,867	6,491,671
Loss from operations	-6,923,457	-6,290,933
Other income (expense)
Gain incurred in connection with troubled debt restructuring, net	0	46,978
Amortization of debt discount	-1,373,143	-444,450
Loss on extinguishment of debt	-176,496	0
Loss from warrants/derivatives issued with debt greater than debt carrying value	-185,000	0
Gain (Loss) on fair market valuation of derivatives	1,167,000	-91,000
Interest and financing expense, net	-1,001,065	-760,132
Other expense, net	-1,568,704	-1,248,604
Net loss before taxes	-8,492,161	-7,539,537
Benefit from sale of state net operating loss credits	374,145	3,351,645
Net loss	-8,118,016	-4,187,892
Preferred dividend	1,371,006	1,560,200
Net loss applicable to common shareholders	($9,489,022)	($5,748,092)
Net loss per share attributable to common shareholders - basic and diluted	($0.11)	($0.10)
Weighted average number of common shares outstanding - basic and diluted	89,362,341	55,307,453

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation	$914,479	$611,500

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholder's Equity (USD $)	Total	Series B Preferred Stock	Series C Preferred Stock	Series G Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance at Dec. 31, 2012	($4,551,213)	$130,282	$64,763	$7,147,465	$48,708	$68,606,679	($80,549,110)
Beginning Balance (in shares) at Dec. 31, 2012		65,141	64,763	150,938	48,707,103
Issuance of common stock for services	324,270			122,000	1,637	200,633
Issuance of common stock for services (in shares)				4,000	1,637,500
Issuance of common stock for interest	560,248			153,740	2,852	403,656
Issuance of common stock for interest (in shares)				4,307	2,851,711
Issuance of common stock for compensation	505,509				6,391	499,118
Issuance of common stock for compensation (in shares)					6,390,625
Warrants issued for compensation	206,700					206,700
Preferred stock converted into common stock	0			-741,950	3,934	738,016
Preferred stock converted into common stock (in shares)				-15,739	3,934,750
Debt converted into equity	55,188			55,188
Debt converted into equity (in shares)				2,044
Issuance of preferred stock for assets	140,000			140,000
Issuance of preferred stock for assets (in shares)				8,000
Loss on extinguishment of debt	0			358,641		-358,641
Loss on extinguishment of debt (in shares)				14,360
Preferred stock dividend	0			1,560,200		-1,560,200
Preferred stock dividend (in shares)				31,204
Stock retired	0			-52,000	-1,060	53,060
Stock retired (in shares)				-1,040	-1,060,241
Net loss	-4,187,892						-4,187,892
Ending Balance at Dec. 31, 2013	-15,820,756	130,282	64,763	8,743,284	62,462	68,789,021	-84,737,002
Ending Balance (in shares) at Dec. 31, 2013		65,141	64,763	198,074	62,461,448
Issuance of common stock for services	636,388			0	3,768	632,620
Issuance of common stock for services (in shares)				0	3,767,500
Issuance of common stock for interest	765,676			612,924	1,052	151,700
Issuance of common stock for interest (in shares)				18,400	1,052,437
Issuance of common stock for compensation	1,485,422				6,627	1,478,795
Issuance of common stock for compensation (in shares)					6,627,069
Exercise of cashless warrants	0				342	-342
Exercise of cashless warrants (in shares)					341,830
Preferred stock converted into common stock	0			-2,036,250	18,113	2,018,137
Preferred stock converted into common stock (in shares)				-40,725	18,113,250
Debt converted into equity	1,948,075			53,460	50,937	1,843,678
Debt converted into equity (in shares)				1,070	50,937,505
Loss on extinguishment of debt	0			208,287		-208,287
Loss on extinguishment of debt (in shares)				10,000
Cost of debt rolled for related party	-14,986					-14,986
Preferred stock dividend	0			1,371,006		-1,371,006
Preferred stock dividend (in shares)				60,157
Net loss	-8,118,016						-8,118,016
Ending Balance at Dec. 31, 2014	($19,327,624)	$130,282	$64,763	$8,952,711	$143,301	$73,319,330	($92,855,018)
Ending Balance (in shares) at Dec. 31, 2014		65,141	64,763	246,976	143,301,039

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows from Operating Activities:
Net Loss	($8,118,016)	($4,187,892)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss (gain) on extinguishment of debt	176,496	0
(Gain) loss on derivatives	-1,167,000	91,000
Amortization of intangible assets	1,576	1,551
Amortization of debt discount	1,373,143	444,450
Stock issued for services	334,238	202,270
Stock issued for compensation	1,479,972	505,509
Stock issued for interest expense and financing expenses	285,196	406,508
Warrant grants issued for compensation and services	0	206,700
Equity instruments issued with debt greater than debt carrying amount	185,000	0
Inventory reserve	0	-49,200
Change in assets and liabilities:
Accounts receivable	129,690	-472,297
Receivable from the Technology Business Tax Certificate Transfer Program	2,981,499	-1,147,429
Deferred cost of goods sold	569,036	-569,036
Inventories	-266,089	-366,810
Prepaid expenses	-20,369	3,044
Deposits	319,683	-418,892
Accounts payable and accrued expenses	372,375	2,326,763
Deferred revenue	-1,269,470	1,269,470
Customer prepayments	0	-39,970
Net cash used in operating activities	-2,633,041	-1,841,239
Cash Flows from Investing Activities:
Business acquisition	0	-100,000
Purchase of intangible assets	0	-41,000
Net cash used in investing activities	0	-141,000
Cash Flows from Financing Activities:
Proceeds from debt	3,060,030	3,331,688
Repayment of debt	-528,000	-1,251,522
Net cash provided by financing activities	2,532,030	2,080,166
Net (decrease) increase in cash	-101,011	97,927
Cash at beginning of year	106,773	8,846
Cash at end of year	5,762	106,773
Supplemental disclosure of cash and non-cash investing and financing transactions:
Interest paid	215,855	86,169
Income taxes paid	1,500	5,500
Debt converted to Convertible Preferred Stock Series G shares	53,460	55,188
Convertible Preferred Stock Series G shares issued for financing	$612,924	$153,740

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization and business
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey. Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science. Millennium’s principal source of revenue is from sales of its nutraceutical supplements.
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the “Company” or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., which is the holding company for its subsidiary Millennium Biotechnologies, Inc. (the “Subsidiary” or "Millennium").
	Reclassifications
	Certain reclassifications have been made to the 2013 financial statements to conform to the consolidated 2014 financial statement presentation. These reclassifications had no effect on net losses or cash flows as previously reported.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
	Use of Estimates
	The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on our experience and on various assumptions we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions.
	Cash and Cash Equivalents
	Cash and all highly liquid investments with a maturity of three months or less from the date of purchase, including money market mutual funds, short-term time deposits, and government agency and corporate obligations, are classified as cash and cash equivalents.
	Accounts Receivable
	The Company continuously monitors collections and payments from our customers and regularly adjusts credit limits of customers based upon payment history and a customer’s current credit worthiness, as judged by us. There was no allowance for doubtful accounts as of December 31, 2014 and 2013.
	Receivable from Technology Business Tax Certificate Transfer Program
	The receivable is from the Company selling the New Jersey State net operating loss carry forwards. The Company was able to transfer $375,645 of total available tax benefits of $375,645 for the year ended December 31, 2014. The receivable was collected on January 16, 2015. The Company was able to transfer $3,357,144 of total available tax benefits of $3,357,144 for the year ended December 31, 2013. The receivable was collected on January 23, 2014. The Company paid a fee of $33,808 and $302,143 for the years ended December 31, 2014 and 2013, respectively, in connection with the approval of the Tax Certificate Transfer Program.
	Goodwill
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment. At the conclusion of our test the Company has realized that there has not been any impairment.
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation, which includes amortization of assets under capital leases, is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred. As of December 31 2014 and 2013, all property and equipment has been fully depreciated.
	Patents
	Patents are capitalized and amortized over 240 months. Amortization expense was $1,576 and $1,551 for 2014 and 2013, respectively.
	Evaluation of Long-Lived Assets
	Long-lived assets are assessed for recoverability on an ongoing basis as impairment indicators arise. In evaluating the fair value and future benefits of long-lived assets, their carrying value would be reduced by the excess, if any, of the long-lived asset over management’s estimate of the anticipated undiscounted future net cash flows of the related long-lived asset.
	Revenue Recognition
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which generally occurs at shipping (F.O.B. terms). Upon shipment, the Company has no further performance obligations and collection is reasonably assured as the majority of sales are paid for prior to shipping.
	Discounts are reductions to invoiced amounts offered to customers for payment within a specified period and are estimated upon sale utilizing historic customer payment experience.
	Consistent with industry practice, the Company maintains a return policy that allows customers to return product within a specified period prior and subsequent to the expiration date. The Company’s estimate of the provision for returns is generally based upon historic experience with actual returns.
	Price adjustments, which include shelf stock adjustments, are credits issued to reflect decreases in the selling prices of products. Shelf stock adjustments are based upon the amount of product which the customer has remaining in its inventory at the time of the price reduction. Decreases in selling prices are discretionary decisions made by the Company to reflect market conditions. Amounts recorded for estimated price adjustments are based upon specified terms with direct customers, estimated launch dates of competing products, estimated declines in market price and, in the case of shelf stock adjustments, estimates of inventory held by the customer.
	Certain retailers require guaranteed sales. Revenue is recognized as sales are made to the retail consumer.
	Advertising costs
	Advertising costs are charged to operations when incurred. Advertising expense was $31,243 and $8,157 for the years ended December 31, 2014 and 2013, respectively.
	Shipping and Handling Costs
	Shipping costs of $130,581 and $43,299 are included in cost of sales for the years ended December 31, 2014 and 2013, respectively. Handling costs of $112,005 and $44,467 are included in general and administrative expenses for the years ended December 31, 2014 and 2013, respectively.
	Stock and Warrant Based Compensation
	Stock and warrant based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period of the grant). Compensation expense is recognized based on the estimated grant date fair value method using the Black-Scholes valuation model. The Company account for the issuance of stock and warrants for services based on the estimated fair value of options and warrants using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly based on the subjective assumptions used in the pricing model.
	We account for the issuance of stock and warrants for services from non-employees based on an estimate of the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly if we were to use different assumptions.
	The Company issued 2,500,000 warrants, during the year ended December 31, 2014 for an expense of $25,000 and 1,140,000 warrants, that vested over three years, for an expense of $206,700 during the year ended December 31, 2013. The Company did not issue any stock options during the year ended December 31, 2014 and 2013, respectively.
	Income Taxes
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. Accordingly, for Federal and state income tax purposes, the benefit for income taxes has been offset entirely by a valuation allowance against the related federal and state deferred tax assets for the years ended December 31, 2014 and 2013.
	Loss Per Common Share
	Basic and diluted loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods. Potential common shares used in computing diluted earnings per share related to stock options, warrants, convertible preferred stock and convertible debt which, if exercised, would have an anti- dilutive effect on earnings per share, and there for have not been included, Anti-dilutive securities not included in net loss per share calculations for the years presented include:
		December 31,
		2014	2013
	Potentially dilutive securities:
	Convertible debt and accrued interest	390,211,843	10,751,345
	Liability of shares to be issued	4,314,380	3,330,000
	Convertible Preferred stock	154,555,045	49,713,545
	Outstanding time-based warrants	21,292,144	19,323,406
	Fair Value of Financial Instruments
	The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The levels are defined as follows:
	Level 1 – quoted prices for identical instruments in active markets;
	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
	Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	For financial instruments including cash, prepaid expenses and other current assets, short-term debt, accounts payable and accrued expenses, it was assumed that the carrying values approximated fair value because of their short-term maturities.
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
	Research and Development
	Research and development costs are expensed as incurred.

GOING_CONCERN

GOING CONCERN	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
GOING CONCERN	2. GOING CONCERN
	The Company’s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing.  Management believes they can raise the appropriate funds needed to support their business plan and develop an operating, cash flow positive company.
	However the Company has incurred substantial net losses for the years ended December 31, 2014 and 2013 and has accumulated a deficit of approximately $93 million at December 31, 2014 and $85 million at December 31, 2013. The Company has not been able to generate sufficient cash from operating activities to fund its ongoing operations. There is no guarantee that the Company will be able to generate enough revenue and/or raise capital to support its operations.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The consolidated financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern.

BUSINESS_ACQUISITION

BUSINESS ACQUISITION	12 Months Ended
	Dec. 31, 2014
Business Acquisition Cost Of Acquired Entity Purchase Prices [Abstract]
BUSINESS ACQUISITION	3. BUSINESS ACQUISITION
	On January 9, 2013 (the “Acquisition date”), the Company entered into a definitive agreement pursuant to which it acquired, through its Millennium Biotechnologies, Inc. wholly-owned subsidiary, the trademark of Bikini Ready® and the brand SlimTrim™. Under the agreement the Company acquired the URL’s, formula and customer list. Under the terms of this agreement the Company paid $100,000 cash and 8,000 shares of Series G preferred stock valued at $140,000.
	The transaction was accounted for as a purchase business combination. We account for business combinations in accordance with the acquisition method. The acquisition method of accounting requires that assets acquired and liabilities assumed be recorded at their fair values on the date of a business acquisition. The excess of the purchase price over the fair value of assets acquired is recognized as goodwill. Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but with the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income. Our consolidated financial statements and results of operations reflect an acquired business from the completion date of an acquisition. The results from operations for the period from acquisition date to December 31, 2013 have been included in the Company’s consolidated statement of operations. Pro forma information with respect to the acquisition are not included in these financial statements as the information is not material.
	In accordance with generally accepted accounting principles, intangible assets are recorded at fair values as of the date of the transaction. The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:
	Intangible assets, trademarks	$	100,000
	Intangible assets, customer list		5,000
	Goodwill		135,000
	Purchase Price	$	240,000
	Intangible assets with estimated useful lives are amortized over a 5 year period. The goodwill is not amortized for financial statement purposes in accordance with generally accepted accounting principles.

CONCENTRATIONS_OF_BUSINESS_AND

CONCENTRATIONS OF BUSINESS AND CREDIT RISK	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
CONCENTRATIONS OF BUSINESS AND CREDIT RISK	4. CONCENTRATIONS OF BUSINESS AND CREDIT RISK
	The Company maintains cash balances in several financial institutions which currently are insured by the Federal Deposit Insurance Corporation. Balances in these accounts may, at times, exceed the federally insured limits.
	The Company provides credit in the normal course of business to customers and performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information.
	For the year ended December 31, 2014, two significant customers (defined as contributing at least 10%) accounted for 36% (19%, and 17%) of net sales. For the year ended December 31, 2013, three significant customers (defined as contributing at least 10%) accounted for 55% (31%, 13%, and 11%) of net sales. The loss of any of these customers could have a material adverse effect on our business.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2014
Disclosure - Inventories [Abstract]
INVENTORIES	5. INVENTORIES
	Inventories are stated at the lower of cost or market and consist of finished goods and packaging for the Company’s Surgex™, Bikini Ready™, SlimTrim and Martha Stewart™ Essentials product lines. Cost-of-goods sold are calculated using the weighted average costing method. Inventories consisted of the following:
		December 31,
		2014		2013
	Finished Goods	$	634,578	$	378,472
	Packaging		51,697		41,714
			686,275		420,186
	Less: Reserve for obsolescence		-		-
	Total	$	686,275	$	420,186

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	6. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following:
		December 31,
		2014		2013
	Accounts payable	$	3,067,081	$	2,866,017
	Accrued interest		833,215		1,016,584
	Accrued rent expense		135,874		135,874
	Accrued salaries, bonuses and payroll taxes		125,391		824,492
	Accrued professional fees		218,593		230,433
	Owed to officers		36,570		16,088
		$	4,416,724	$	5,089,488

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	7. FAIR VALUE MEASUREMENTS
	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis:
	December 31, 2014	Level I		Level II		Level III		Total
	Derivative liability						910,590		910,590
	Total liabilities	$	-	$	-	$	910,590	$	910,590
	31-Dec-13	Level I		Level II		Level III		Total
	Derivative liability						318,000		318,000
	Total liabilities	$	-	$	-	$	318,000	$	318,000
	Liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level3):
		Derivative
		Liabilities
	1-Jan-14	$	-318,000
	Issuance of notes with derivatives		-2,845,000
	Derivative debt converted into equity		1,085,410
	Gain on fair market valuation of derivatives		1,167,000
	31-Dec-14	$	-910,590

DEBT

DEBT	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
DEBT	8. DEBT
	Debt is as follows:
		December 31,
		2014		2013
	Convertible Promissory Note to an accredited investor dated May 20, 2003, maturing May 20, 2004, now due on demand, bearing interest at a rate 8% per annum payable in restricted shares of common stock. The Note is convertible at the option of the holder into common stock at the rate of $20.00 per share.		30,000		30,000
	One demand loan extended by an investor in March 2004 and January 2005, bearing interest at 12% per year, now due on demand. Principal in the amount of $5,000 was paid in September 2013. The balance outstanding was converted into common stock in January 2014.		-		10,000
	Two promissory notes issued to accredited investors in September 2006, maturing at various dates between November 30, 2006 and January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		48,000		48,000
	Two promissory notes issued to accredited investors in October 2006, maturing on January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		44,000		44,000
	One promissory note issued to an accredited investors in January 2007, maturing on March 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		75,000		75,000
	One promissory note issued to an accredited investor in May 2007, maturing on September 30, 2007, now due on demand. The note carried interest at the rate of 10% per year until maturity and thereafter is subject to a rate of 12% per year. The note calls for the interest payable in common stock, calculated at $8.00 per share. The note is convertible into common shares at the rate of $8.00 /share.		25,000		25,000
	Promissory note, originally in the amount of $2,710,563 issued to a service provider, due on July 31, 2008. The note carried interest at the rate of 10% per year compounded monthly. In November 2009, the creditor and the Company entered into an agreement whereby, against payment of $110,000 in cash, the principal amount of the note was reduced to $400,000.		400,000		400,000
	Two promissory notes, issued in November 2009 as part of a series of debt restructuring transactions whereby existing promissory notes, most of which were past due or payable on demand, and interest accrued thereon were exchanged into Units at the rate of 1:1 between old note principal plus accrued interest to Unit price, at a price of $100,000 per Unit. Each Unit consisted of a 30 month promissory note for $100,000, carrying interest at 15% per year and 100 shares of Series F Convertible Preferred Stock, whereby every “F” share was converted into 120,000 common shares on April 20, 2010. The notes and interest accrued thereon are repayable in five quarterly installments beginning 18 months after issue. Six of the notes converted in September 2011 into Series G Convertible Preferred Stock at the rate of one share of G Preferred per $73.50 of principal and accrued interest. The Unit Note holders were entitled to a reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder’s Unit Note in the Series G Preferred equity offering. In April 2013, $67,021 of principal plus accrued interest was converted into 2,044 shares of Series G Preferred Stock, realizing a gain of $46,978. In April 2014, $85,726 of principal plus accrued interest was converted into 750,000 shares of common stock, realizing a gain of $18,378.		-		85,726
	One promissory note was issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The note is convertible into Series G Preferred Stock. The note bears interest at 10% per year and matures on March 31, 2015.		29,606		29,606
	Five promissory notes issued to accredited investors in March and April 2012, maturing thirty-six months after issuance. The note carries interest at the rate of 10% per year until maturity and are payable quarterly in common stock valued at $0.20 per share. The notes are convertible into common shares at the rate of $0.20 share. One note in the principal amount of $25,000 was paid off in January 2013. One note in the principal amount of $50,000 converted into common stock in March 2014.		70,139		74,306
	Two promissory notes issued to an accredited investor in March 2013, maturing twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes are convertible into common shares at the rate of $0.25/ share.		112,288		97,924
	Four notes issued to an accredited investor in April, May and June 2013, maturing between eight to twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes and accrued interest were repaid in January 2014.		-		191,551
	One promissory note issued to an accredited investor in May 2013, maturing ten months after issuance. The note carries interest at the rate of 15% per year until maturity. The note is convertible into common shares at the rate of $0.20/ share.		-		96,012
	One promissory note issued to an accredited investor in May 2013, maturing nine months after issuance. The note carries interest at the rate of 15% per year until maturity. The note and accrued interest was repaid in February 2014.		-		95,948
	One promissory note re-issued to an accredited investor in August 2013, maturing seven months after re-issuance. The note carries interest at the rate of 10% per year until maturity. The note and accrued interest was repaid in January 2014.		-		53,000
	One promissory note issued to an accredited investor in August 2013, maturing six months after issuance. The note carries interest at the rate of 15% per year until maturity.		26,521		24,197
	Two promissory notes issued to an accredited investor in March and April 2014, maturing eighteen months after issuance. The note carries interest at the rate of 15% per year until maturity.		269,368		-
	One promissory note issued to an accredited investor in May 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		439,052		-
	One promissory note issued to an accredited investor in July 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		507,425		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		19,863		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 4% per year. The note is convertible into common shares at the rate of 55% of lowest trading price over the past 20 day trading period.		40,685		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		65,526		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 55% of lowest trading price over the past 20 day trading period.		35,055		-
	Three promissory note issued to an accredited investors in December 2014, maturing one month after issuance. The note carries interest at the rate of 24% per year until maturity. The note and accrued interest was repaid in January 2015.		225,000		-
	Total Debt		2,462,528		1,380,270
	Less short-term portion		2,462,528		1,276,358
	Long-term portion	$	-	$	103,912
	Included in total debt as of December 31, 2014 and 2013 of $2,462,528 and $1,380,270 is an unamortized debt discount of     $1,047,888 and $70,062, respectively.
	Debt to affiliates is as follows:
		December 31,
		2014		2013
	Promissory note issued to an accredited investor in March 2009. The note was due on September 26, 2009 and carrying interest at 24% per year. In March 2014 the note and accrued interest was converted into Preferred Stock Series G.	$	-	$	33,000
	Promissory note issued to an accredited investor in July 2009. The note was due on October 28, 2009 and carrying interest at 36% per year.		16,600		16,600
	Purchase order financing note issued in May 2010, carry interest at 24% per year and due on demand. The note was purchased by another debt holder and converted into common stock.		-		100,000
	Four promissory notes were issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The notes are convertible into common shares at a rate of $0.08/share. The notes bear interest at 10% per year and mature on March 31, 2015.		1,425,522		1,425,522
	Eight promissory notes issued to accredited investors in May through August 2013, maturing six to nine months after issuance. The notes carry interest at the rate of 15% per year. In May 2014 some of the notes were purchased by another debt holder, the balance was rolled into a new note for $1,250,000.		-		2,104,584
	Four promissory notes issued to accredited investors in July 2013, maturing seven months after issuance. The notes carry interest at the rate of 12% per year. In May 2014 some of the notes were purchased by another debt holder, the balance was rolled into a new note for $1,250,000.		-		589,544
	One promissory note issued to accreditied investor in May 2014, maturing January 23, 2015. The note carry interest at the rate of 12% per year.		1,250,000		-
	Six promissory notes issued to accredited investors in March, April and June 2014 maturing six months after issuance. The notes carry interest at the rate of 12% per year.		300,030		-
	One promissory note issued to accredited investor in May 2014, maturing February 23, 2015. The note carries interest at the rate of 12% per year.		510,000		-
	One promissory note issued to accredited investor in June 2014, maturing March 3, 2015. The note carries interest at the rate of 12% per year.		200,000		-
	Two promissory notes issued to accredited investor in September 2014, maturing in October 2014 and April 2015. The note carries interest at the rate of 12% per year.		126,923		-
	Total debt to affiliates		3,829,075		4,269,250
	Less short-term portion due to affiliates		3,829,075		2,843,728
	Total Long-Term Debt to affiliates	$	-	$	1,425,522
	Included in total debt as of December 31, 2014 and 2013 of $3,829,075 and $4,269,250 is an unamortized debt discount of $0     and $82,560, respectively.
	The following is a schedule of future minimum debt payments as of December 31, 2014:
	Year Ending December 31,
	2015	$	3,829,075
	Total minimum payments required	$	3,829,075
	2013 Modification of Debt
	The following debt instruments were modified in 2013. The modification of debt included the addition of a conversion feature therefore requiring the Company to record the transaction in accordance with ASC 470 “Debt” modification of debt accounting.
	At December 31, 2013, the Company had promissory notes issued to four affiliated investors with an outstanding balance of $1,455,128, which were due on demand. As of December 31, 2013, the Company reached an agreement with the investors to extend the debt for fifteen months. At the date of extension, the debt payable was $1,455,128.  The fair value of the new debt is $1,096,487, which includes the fair value of the conversion feature of $358,641.  The conversion rate on the new convertible note is $0.20 per share of common stock.  As of December 31, 2013 the loss on debt modification of $358,641 has been included in the accompanying Statement of Stockholders’ Deficit.

INCOME_TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
INCOME TAX	9. INCOME TAX
	The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not believe it has any tax positions that should not be recognized under FASB ASC 740-10.
	The reconciliation of the effective income tax rate to the Federal statutory rate is as follows:
		2014		2013
	Federal Income Tax Rate	-34	%	-34	%
	State Income Tax, Net of Federal Benefit	-5.94	%	-5.94	%
	Change in valuation allowance	39.94	%	39.94	%
	Sale of New Jersey NOL	-4.4	%	-46	%
	Effective Income Tax Rate	-4.4	%	-46	%
	As of December 31, 2014, the Company has net operating loss carry forwards of approximately $65,000,000 that can be utilized to offset future taxable income for Federal income tax purposes through 2031. Net operating loss carry forwards expire starting in 2024 through 2032. Utilization of these net loss carry forwards is subject to the limitations of Internal Revenue Code Section 382.  Because of the current uncertainty of realizing the benefit of the tax carry forward, a valuation allowance equal to the tax benefit for deferred taxes has been established.
	Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. Because of the current uncertainty of realizing the benefit of the tax carry forward, a valuation allowance equal to the tax benefit for deferred taxes has been established. The full realization of the tax benefit associated with the carry forward depends predominantly upon the Company's ability to generate taxable income during the carry forward period.
	Significant components of the Company's deferred tax assets and liabilities are summarized as follows:
		December 31,
		2014			2013
	Deferred tax assets		26,899,000			23,165,000
	Less: Valuation Allowance		-26,899,000			-23,165,000
	Net Deferred Tax Assets	$	-		$	-
	The Company’s deferred income tax valuation allowance increased by $3,734,000 to $26,899,000 as of December 31 2014.

CAPITAL_STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2014
Stockholders Equity Note [Abstract]
CAPITAL STOCK	10. CAPITAL STOCK
		a)	Series B and C, Convertible Preferred Stock and Common Stock
	Convertible Series B preferred shares ("Series B") are non-dividend bearing, and are convertible into shares of the Company’s common stock at any time at the option of the holder and are subject to adjustment in accordance with certain anti-dilution clauses. Cumulative Series C preferred shares ("Series C") are not convertible but are entitled to cumulative cash dividends at the rate of $.65 per share per annum, payable in each year commencing the year after all the shares of Series B are retired. There were no cumulative cash dividends payable as of December 31, 2014 and 2013, respectively.
		a.1)	Voting Rights
	The holders of Series B and Series C preferred stock have no voting rights. Each share of common stock is entitled to one vote.
		a.2)	Dividend Restrictions
	No cash dividends may be declared or paid on the Company’s common stock if, and as long as, Series B preferred stock is still outstanding or there are dividends in arrears on outstanding shares of Series C preferred stock. No dividends may be declared on Series C shares if, and as long as, any Series B shares are outstanding. There were no cumulative cash dividends payable as of December 31, 2014 and 2013, respectively.
		a.3)	Other information is summarized as follows:
			Convertible		Cumulative
			Series B		Series C
	Number of common shares to be issued upon conversion of each preferred share			10		None
	Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)		$	2	$	10	-1
	(1) Plus any dividend in arrears.
	b) Series G Convertible Preferred Stock
	b.1) Authorized Number
	Four Hundred Thousand (400,000) of the authorized shares of Preferred Stock are hereby designated “Series G Convertible Preferred Stock” par value $1.00 per share, stated value $50 (“G Preferred”).
	b.2) Designation
	The rights, preferences, privileges, restrictions and other matters relating to G Preferred, as filed with the Secretary of State, Delaware, are as follows:
	(1)            Dividends   The shares of G Preferred shall bear a 10% annual dividend, payable quarterly in kind based on the equivalent of 90% of the average of the last ten trading day closing price of the Common Stock prior to the dividend payment date.
	(2)            Distribution of Assets Upon Liquidation   In the event the Company shall be liquidated, dissolved or wound up, whether voluntarily or involuntarily, each holder of shares of G Preferred, has a liquidation preference before any payment or distribution on the Common Stock or on any other class of stock ranking junior to the G Preferred up to the Stated Value and, thereafter, shares ratably in proceeds available along with the holders of shares of Common Stock and any other share of stock entitled to payment upon liquidation.
	(3)            Voting Rights   (a)  Each holder of outstanding shares of G Preferred shall be entitled to the number of votes equal to the number of whole shares of Common Stock into which the share of G Preferred held by such holder would then be convertible assuming a sufficient number of shares of Common Stock were then authorized and available for issuance, at each meeting of the stockholders of the Company (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Company for their action or consideration (including without limitation, any matter voted on together with the holders of Common Stock).  Except as provided by law, by any of the provisions contained herein or by the provisions establishing any other series of stock, holders of G Preferred shall vote together with the holders of Common Stock as a single class.
	(4)            Conversion of G Preferred   At the option of the holder each share of G Preferred may be converted into fully paid and non-assessable shares of the Company’s Common Stock at the rate of 625 shares of Common Stock for each share of G Preferred. The holder of each G Preferred has anti-dilution rights whereby any Common Stock shares that are issued or sold at a price less than the Conversion Rate in effect, then the Conversion Rate shall be reduced to an amount equal to the New Securities Issuance Price.
	c) Common Stock
	c.1) Authorized Number
	Two Billion (2,000,000,000) of the authorized shares of Common Stock are hereby designated “ Common Stock” par value $0.001 per share.
	The cost of all share-based awards to employees, including grants of warrants and restricted stock, is recognized in the financial statements based on the fair value of the awards at grant date. The fair value of the warrant award is determined using the Black-Scholes valuation model on the date of grant. The fair value of the share-based awards is recognized as stock-based compensation expense on a straight-line basis over the requisite service period from the date of grant. As of December 31, 2014, there was approximately $43,125 of total unrecognized compensation cost related to non-vested warrant based compensation arrangements granted under the Company’s compensation plan. The cost is expected to be recognized over a period of 2 years. This expected cost does not include the impact of any future stock-based compensation awards.

OPTIONS_AND_WARRANTS

OPTIONS AND WARRANTS	12 Months Ended
	Dec. 31, 2014
Stock Warrants Disclosure [Abstract]
OPTIONS AND WARRANTS	11. OPTIONS AND WARRANTS
	In February 2000, Millennium adopted its 2001 Stock Option Plan ("The 2001 Plan"). The 2001 Plan provides that certain options granted thereunder are intended to qualify as "Incentive Stock Options" (ISO) within the meaning of Section 422A of the United States Internal Revenue Code of 1986, while non-qualified options may also be granted under the Plan. The Plan provided for the grant of options for up to 500,000 shares. The purchase price per common stock deliverable upon exercise of each ISO shall not be less than 100% of the fair market value of the common stock on the date such option is granted. If an ISO is issued to an individual who owns, at the time of grant, more than 10% of the total enhanced voting power of all classes of Millennium’s common stock, the exercise price of such option shall be at least 110% of the fair market value of the common stock on the date of grant and the term of the option shall not exceed five years from the date of grant. The purchase price of shares subject to non-qualified stock options shall be determined by a committee established by the Board of Directors with the condition that such prices shall not be less than 85% of the fair market value of the common stock at the time of grant. Millennium had no options issued pursuant to this Plan as of December 31, 2014 and 2013, respectively.
			December 31, 2014					December 31, 2013
			Shares			Weighted		Shares		Weighted
						Average				Average
						Exercise				Exercise
						Price				Price
	Warrants outstanding - beginning of year			19,323,406		$	0.2		18,190,906	$	0.225
	Warrants exercised			-531,262			0.104		-		-
	Warrants granted			2,500,000			0.2		1,140,000		0.185
	Warrants expired			-			0		-7,500		60
	Warrants outstanding - end of year			21,292,144		$	0.223		19,323,406	$	0.2
	Warrants price range at end of year			$0.10 - $16.00					$0.10 - $16.00
	Warrants price for exercised shares			$0.00					$0.00
	The following table summarizes information about fixed-price warrants outstanding
	Range of Exercise			Number			Average	Weighted		Number		Weighted
	Prices			Exercisable at			Remaining	Average		Exercisable at		Average
				December 31,			Contractual	Exercise Price		December 31,		Exercise Price
				2014			Life			2013
	$	0.1			7,500,000		35 Mo’s	$	0.1		7,500,000	$	0.1
	$	0.17			8,002,144		79 Mo’s	$	0.17		8,033,406	$	0.17
	$	0.2			6,227,500		25 Mo’s	$	0.2		3,727,500	$	0.2
	$	16			62,500		60 Mo’s	$	16		62,500	$	16
	$	60			-			$	60		-	$	60
					21,292,144						19,323,406
	Total compensation cost recognized in the income statement for stock-based employee and directors’ compensation awards was $1,592,552 and $457,500 in 2014 and 2013, respectively.
	The cost of all share-based awards to employees, including grants of warrants and restricted stock, is recognized in the financial statements based on the fair value of the awards at grant date. The fair value of the warrant award is determined using the Black-Scholes valuation model on the date of grant. The fair value of the share-based awards is recognized as stock-based compensation expense on a straight-line basis over the requisite service period from the date of grant. As of December 31, 2014, there was approximately $0 of total unrecognized compensation cost related to non-vested warrant based compensation arrangements granted under the Company’s compensation plan. The cost is expected to be recognized over a period of 2 years. This expected cost does not include the impact of any future stock-based compensation awards.

OPERATING_LEASE_LICENSE_AND_EM

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS	12 Months Ended
	Dec. 31, 2014
Operating Lease And License And Employment Commitments [Abstract]
OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS	12. OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS
	The Company leases office space in Newark, NJ under an operating lease.
	The following is a schedule of future minimum rental payments (exclusive of allocated expenses) required under operating leases that have initial or non-cancelable lease terms in excess of one year as of December 31, 2014:
	Year Ending December 31,
	2015		50,400
	2016		12,600
	Total minimum payments required	$	63,000
	Rent expense for the Company under operating leases for the years ended December 31, 2014 and 2013 was $50,400 and $47,282, respectively.
	The Company entered into a license agreement with minimum royalty payments totaling $13,600,000. In the year ended December 31, 2014, $1,350,000 has been paid for the year ending December 31, 2014 with a remaining balance from 2014 of $450,000 nor payment due January 1, 2015 in the amount of $525,000 or the payment due April 1, 2015 in the amount of $525,000. We are in discussions with MSLO to work out terms of payment. If we are unable to come to acceptable terms, we would be in default of the terms of the license agreement.
	Year Ending December 31,
	2015		2,100,000
	2016		2,700,000
	2017		3,200,000
	2018		3,800,000
		$	11,800,000
	Pursuant to the Summary of Debt Reorganization and Financing dated July 14, 2011, Mr. James salary was amended to reduce his salary to $150,000 per annum until the Company reaches three consecutive fiscal quarters of positive Net Income at which point his annual salary will increase to $200,000. The gross-up provisions with regards to any issuances under the Management Warrant Grant Program have been eliminated. Mr. James will receive a bonus of $25,000 upon receiving three consecutive fiscal quarters of positive Net Income.

STOCK_GRANTED_FOR_SERVICES_AND

STOCK GRANTED FOR SERVICES AND FINANCING	12 Months Ended
	Dec. 31, 2014
Stock Based Compensation Disclosure [Abstract]
STOCK GRANTED FOR SERVICES AND FINANCING	13. STOCK GRANTED FOR SERVICES AND FINANCING
	During the year ended December 31, 2014 the Company issued 3,767,500 shares of Common Stock valued at $334,238 for services. The value of the Common Stock is the fair market value on the date of issuance.
	During the year ended December 31, 2014 the Company issued 6,627,069 shares of Common Stock valued at $1,479,972 for compensation. The value of the Common Stock is the fair market value on the date of issuance.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS
	During 2014 and 2013, we also issued restricted stock awards and warrants to certain officers and directors, as follows:
	Mr. James received 2,000,000 shares of common stock in March 2014 valued at $550,000, in recognition of services performed. The value of the Common Stock is the fair market value on the date of issuance.
	Mr. Kras received 2,000,000 shares of common stock in March 2014 valued at $550,000, in recognition of services performed. The value of the Common Stock is the fair market value on the date of issuance.
	Mr. DeLucia received 500,000 shares of common stock in March 2014 valued at $140,000, for director fees. The value of the Common Stock is the fair market value on the date of issuance.
	Refer to footnote 8 for affiliated debt transactions.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2014
Litigation Settlements [Abstract]
LITIGATION	15. LITIGATION
	All legal matters contained within this Note to the Financial Statement have been accrued for on the Company’s balance sheet as a liability as of December 31, 2014.
	Creative Healthcare Solutions, LLC vs. Millennium Biotechnologies Inc, Ct. of Common Pleas of Delaware County Ohio, Case No. 07 CV H 11 1420)  Millennium was not satisfied with the service rendered by Creative Healthcare Solutions, LLC in 2005 which were associated with the development of Resurgex Select collateral materials developed in December of 2005.  Millennium subsequently was forced to destroy and dispose of over 80% of the materials provided by Creative Healthcare Solutions due to the poor quality of the materials.  Millennium has been unsuccessful in resolving the dispute and subsequently Creative Healthcare Solutions, LLC has filed legal action for demand of payment in the amount of $63,718 for services rendered.  Millennium continues to negotiate a settlement with regards to this legal proceeding.
	Robert Half International vs. Millennium Biotechnologies, Inc. filed on September 30, 2009 in the Superior Court of New Jersey, Law Division, Middlesex County.  Robert Half International claims a total of $18,507 plus costs and fees based upon the Millennium Biotechnologies, Inc.’s failure to pay the plaintiff the fees associated with the full time hiring of an employee.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	16. SUBSEQUENT EVENTS
	The Company received $375,645 on January 16, 2015 from the sale of the New Jersey Technology Business Tax Transfer Program. The Company paid a fee of $33,808 upon the successful receipt of the sale proceeds. The net amount the Company received was $341,837.
	Debt in the principal amount of $379,000 and accrued interest in the amount of $1,775 converted into 61,081,644 common shares of stock.
	In February 2015 the Company raised $75,000 of one year convertible debt paying annual interest at 9.09% The debt is convertible into common stock at 55% of the lowest closing price based on the prior 15 trading days.
	In March 2015 the Company raised $150,000 of one year convertible debt paying annual interest at 12%. The debt is convertible into common stock at 62% of the lowest trading price on the prior 10 trading days.
	In March 2015 the Company raised $110,000 of one year convertible debt paying annual interest at 4%. The debt is convertible into common stock at 55% of the lowest trading price on the prior 15 trading days.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Organization and business	Organization and business
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey. Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science. Millennium’s principal source of revenue is from sales of its nutraceutical supplements.
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the “Company” or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., which is the holding company for its subsidiary Millennium Biotechnologies, Inc. (the “Subsidiary” or "Millennium").
Reclassifications	Reclassifications
	Certain reclassifications have been made to the 2013 financial statements to conform to the consolidated 2014 financial statement presentation. These reclassifications had no effect on net losses or cash flows as previously reported.
Principles of Consolidation	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates
	The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on our experience and on various assumptions we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions.
Cash and Cash Equivalents	Cash and Cash Equivalents
	Cash and all highly liquid investments with a maturity of three months or less from the date of purchase, including money market mutual funds, short-term time deposits, and government agency and corporate obligations, are classified as cash and cash equivalents.
Accounts Receivable	Accounts Receivable
	The Company continuously monitors collections and payments from our customers and regularly adjusts credit limits of customers based upon payment history and a customer’s current credit worthiness, as judged by us. There was no allowance for doubtful accounts as of December 31, 2014 and 2013.
Receivable from Technology Business Tax Certificate Transfer Program	Receivable from Technology Business Tax Certificate Transfer Program
	The receivable is from the Company selling the New Jersey State net operating loss carry forwards. The Company was able to transfer $375,645 of total available tax benefits of $375,645 for the year ended December 31, 2014. The receivable was collected on January 16, 2015. The Company was able to transfer $3,357,144 of total available tax benefits of $3,357,144 for the year ended December 31, 2013. The receivable was collected on January 23, 2014. The Company paid a fee of $33,808 and $302,143 for the years ended December 31, 2014 and 2013, respectively, in connection with the approval of the Tax Certificate Transfer Program.
Goodwill	Goodwill
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment. At the conclusion of our test the Company has realized that there has not been any impairment.
Property and Equipment	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation, which includes amortization of assets under capital leases, is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred. As of December 31 2014 and 2013, all property and equipment has been fully depreciated.
Patents	Patents
	Patents are capitalized and amortized over 240 months. Amortization expense was $1,576 and $1,551 for 2014 and 2013, respectively.
Evaluation of Long-Lived Assets	Evaluation of Long-Lived Assets
	Long-lived assets are assessed for recoverability on an ongoing basis as impairment indicators arise. In evaluating the fair value and future benefits of long-lived assets, their carrying value would be reduced by the excess, if any, of the long-lived asset over management’s estimate of the anticipated undiscounted future net cash flows of the related long-lived asset.
Revenue Recognition	Revenue Recognition
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which generally occurs at shipping (F.O.B. terms). Upon shipment, the Company has no further performance obligations and collection is reasonably assured as the majority of sales are paid for prior to shipping.
	Discounts are reductions to invoiced amounts offered to customers for payment within a specified period and are estimated upon sale utilizing historic customer payment experience.
	Consistent with industry practice, the Company maintains a return policy that allows customers to return product within a specified period prior and subsequent to the expiration date. The Company’s estimate of the provision for returns is generally based upon historic experience with actual returns.
	Price adjustments, which include shelf stock adjustments, are credits issued to reflect decreases in the selling prices of products. Shelf stock adjustments are based upon the amount of product which the customer has remaining in its inventory at the time of the price reduction. Decreases in selling prices are discretionary decisions made by the Company to reflect market conditions. Amounts recorded for estimated price adjustments are based upon specified terms with direct customers, estimated launch dates of competing products, estimated declines in market price and, in the case of shelf stock adjustments, estimates of inventory held by the customer.
	Certain retailers require guaranteed sales. Revenue is recognized as sales are made to the retail consumer.
Advertising costs	Advertising costs
	Advertising costs are charged to operations when incurred. Advertising expense was $31,243 and $8,157 for the years ended December 31, 2014 and 2013, respectively.
Shipping and Handling Costs	Shipping and Handling Costs
	Shipping costs of $130,581 and $43,299 are included in cost of sales for the years ended December 31, 2014 and 2013, respectively. Handling costs of $112,005 and $44,467 are included in general and administrative expenses for the years ended December 31, 2014 and 2013, respectively.
Stock and Warrant Based Compensation	Stock and Warrant Based Compensation
	Stock and warrant based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period of the grant). Compensation expense is recognized based on the estimated grant date fair value method using the Black-Scholes valuation model. The Company account for the issuance of stock and warrants for services based on the estimated fair value of options and warrants using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly based on the subjective assumptions used in the pricing model.
	We account for the issuance of stock and warrants for services from non-employees based on an estimate of the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly if we were to use different assumptions.
	The Company issued 2,500,000 warrants, during the year ended December 31, 2014 for an expense of $25,000 and 1,140,000 warrants, that vested over three years, for an expense of $206,700 during the year ended December 31, 2013. The Company did not issue any stock options during the year ended December 31, 2014 and 2013, respectively.
Income Taxes	Income Taxes
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. Accordingly, for Federal and state income tax purposes, the benefit for income taxes has been offset entirely by a valuation allowance against the related federal and state deferred tax assets for the years ended December 31, 2014 and 2013.
Loss Per Common Share	Loss Per Common Share
	Basic and diluted loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods. Potential common shares used in computing diluted earnings per share related to stock options, warrants, convertible preferred stock and convertible debt which, if exercised, would have an anti- dilutive effect on earnings per share, and there for have not been included, Anti-dilutive securities not included in net loss per share calculations for the years presented include:
		December 31,
		2014	2013
	Potentially dilutive securities:
	Convertible debt and accrued interest	390,211,843	10,751,345
	Liability of shares to be issued	4,314,380	3,330,000
	Convertible Preferred stock	154,555,045	49,713,545
	Outstanding time-based warrants	21,292,144	19,323,406
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The levels are defined as follows:
	Level 1 – quoted prices for identical instruments in active markets;
	Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
	Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	For financial instruments including cash, prepaid expenses and other current assets, short-term debt, accounts payable and accrued expenses, it was assumed that the carrying values approximated fair value because of their short-term maturities.
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
Research and Development	Research and Development
	Research and development costs are expensed as incurred.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Weighted Average Number of Shares	Anti-dilutive securities not included in net loss per share calculations for the years presented include:
		December 31,
		2014	2013
	Potentially dilutive securities:
	Convertible debt and accrued interest	390,211,843	10,751,345
	Liability of shares to be issued	4,314,380	3,330,000
	Convertible Preferred stock	154,555,045	49,713,545
	Outstanding time-based warrants	21,292,144	19,323,406

BUSINESS_ACQUISITION_Tables

BUSINESS ACQUISITION (Tables)	12 Months Ended
	Dec. 31, 2014
Business Combinations [Abstract]
BUSINESS ACQUISITION	The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:
	Intangible assets, trademarks	$	100,000
	Intangible assets, customer list		5,000
	Goodwill		135,000
	Purchase Price	$	240,000

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure - Inventories [Abstract]
Inventory	Inventories consisted of the following:
		December 31,
		2014		2013
	Finished Goods	$	634,578	$	378,472
	Packaging		51,697		41,714
			686,275		420,186
	Less: Reserve for obsolescence		-		-
	Total	$	686,275	$	420,186

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	Accounts payable and accrued expenses consisted of the following:
		December 31,
		2014		2013
	Accounts payable	$	3,067,081	$	2,866,017
	Accrued interest		833,215		1,016,584
	Accrued rent expense		135,874		135,874
	Accrued salaries, bonuses and payroll taxes		125,391		824,492
	Accrued professional fees		218,593		230,433
	Owed to officers		36,570		16,088
		$	4,416,724	$	5,089,488

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis:
	December 31, 2014	Level I		Level II		Level III		Total
	Derivative liability						910,590		910,590
	Total liabilities	$	-	$	-	$	910,590	$	910,590
	31-Dec-13	Level I		Level II		Level III		Total
	Derivative liability						318,000		318,000
	Total liabilities	$	-	$	-	$	318,000	$	318,000
Liabilities measured at fair value on a recurring basis using significant unobservable inputs	Liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level3):
		Derivative
		Liabilities
	1-Jan-14	$	-318,000
	Issuance of notes with derivatives		-2,845,000
	Derivative debt converted into equity		1,085,410
	Gain on fair market valuation of derivatives		1,167,000
	31-Dec-14	$	-910,590

DEBT_Tables

DEBT (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of debt to related parties	Debt is as follows:
		December 31,
		2014		2013
	Convertible Promissory Note to an accredited investor dated May 20, 2003, maturing May 20, 2004, now due on demand, bearing interest at a rate 8% per annum payable in restricted shares of common stock. The Note is convertible at the option of the holder into common stock at the rate of $20.00 per share.		30,000		30,000
	One demand loan extended by an investor in March 2004 and January 2005, bearing interest at 12% per year, now due on demand. Principal in the amount of $5,000 was paid in September 2013. The balance outstanding was converted into common stock in January 2014.		-		10,000
	Two promissory notes issued to accredited investors in September 2006, maturing at various dates between November 30, 2006 and January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		48,000		48,000
	Two promissory notes issued to accredited investors in October 2006, maturing on January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		44,000		44,000
	One promissory note issued to an accredited investors in January 2007, maturing on March 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		75,000		75,000
	One promissory note issued to an accredited investor in May 2007, maturing on September 30, 2007, now due on demand. The note carried interest at the rate of 10% per year until maturity and thereafter is subject to a rate of 12% per year. The note calls for the interest payable in common stock, calculated at $8.00 per share. The note is convertible into common shares at the rate of $8.00 /share.		25,000		25,000
	Promissory note, originally in the amount of $2,710,563 issued to a service provider, due on July 31, 2008. The note carried interest at the rate of 10% per year compounded monthly. In November 2009, the creditor and the Company entered into an agreement whereby, against payment of $110,000 in cash, the principal amount of the note was reduced to $400,000.		400,000		400,000
	Two promissory notes, issued in November 2009 as part of a series of debt restructuring transactions whereby existing promissory notes, most of which were past due or payable on demand, and interest accrued thereon were exchanged into Units at the rate of 1:1 between old note principal plus accrued interest to Unit price, at a price of $100,000 per Unit. Each Unit consisted of a 30 month promissory note for $100,000, carrying interest at 15% per year and 100 shares of Series F Convertible Preferred Stock, whereby every “F” share was converted into 120,000 common shares on April 20, 2010. The notes and interest accrued thereon are repayable in five quarterly installments beginning 18 months after issue. Six of the notes converted in September 2011 into Series G Convertible Preferred Stock at the rate of one share of G Preferred per $73.50 of principal and accrued interest. The Unit Note holders were entitled to a reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder’s Unit Note in the Series G Preferred equity offering. In April 2013, $67,021 of principal plus accrued interest was converted into 2,044 shares of Series G Preferred Stock, realizing a gain of $46,978. In April 2014, $85,726 of principal plus accrued interest was converted into 750,000 shares of common stock, realizing a gain of $18,378.		-		85,726
	One promissory note was issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The note is convertible into Series G Preferred Stock. The note bears interest at 10% per year and matures on March 31, 2015.		29,606		29,606
	Five promissory notes issued to accredited investors in March and April 2012, maturing thirty-six months after issuance. The note carries interest at the rate of 10% per year until maturity and are payable quarterly in common stock valued at $0.20 per share. The notes are convertible into common shares at the rate of $0.20 share. One note in the principal amount of $25,000 was paid off in January 2013. One note in the principal amount of $50,000 converted into common stock in March 2014.		70,139		74,306
	Two promissory notes issued to an accredited investor in March 2013, maturing twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes are convertible into common shares at the rate of $0.25/ share.		112,288		97,924
	Four notes issued to an accredited investor in April, May and June 2013, maturing between eight to twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes and accrued interest were repaid in January 2014.		-		191,551
	One promissory note issued to an accredited investor in May 2013, maturing ten months after issuance. The note carries interest at the rate of 15% per year until maturity. The note is convertible into common shares at the rate of $0.20/ share.		-		96,012
	One promissory note issued to an accredited investor in May 2013, maturing nine months after issuance. The note carries interest at the rate of 15% per year until maturity. The note and accrued interest was repaid in February 2014.		-		95,948
	One promissory note re-issued to an accredited investor in August 2013, maturing seven months after re-issuance. The note carries interest at the rate of 10% per year until maturity. The note and accrued interest was repaid in January 2014.		-		53,000
	One promissory note issued to an accredited investor in August 2013, maturing six months after issuance. The note carries interest at the rate of 15% per year until maturity.		26,521		24,197
	Two promissory notes issued to an accredited investor in March and April 2014, maturing eighteen months after issuance. The note carries interest at the rate of 15% per year until maturity.		269,368		-
	One promissory note issued to an accredited investor in May 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		439,052		-
	One promissory note issued to an accredited investor in July 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		507,425		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		19,863		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 4% per year. The note is convertible into common shares at the rate of 55% of lowest trading price over the past 20 day trading period.		40,685		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 62% of lowest trading price over the past 20 day trading period.		65,526		-
	One promissory note issued to an accredited investor in October 2014, maturing twelve months after issuance. The note carries interest at the rate of 12% per year. The note is convertible into common shares at the rate of 55% of lowest trading price over the past 20 day trading period.		35,055		-
	Three promissory note issued to an accredited investors in December 2014, maturing one month after issuance. The note carries interest at the rate of 24% per year until maturity. The note and accrued interest was repaid in January 2015.		225,000		-
	Total Debt		2,462,528		1,380,270
	Less short-term portion		2,462,528		1,276,358
	Long-term portion	$	-	$	103,912
Schedule of long term debt	Debt to affiliates is as follows:
		December 31,
		2014		2013
	Promissory note issued to an accredited investor in March 2009. The note was due on September 26, 2009 and carrying interest at 24% per year. In March 2014 the note and accrued interest was converted into Preferred Stock Series G.	$	-	$	33,000
	Promissory note issued to an accredited investor in July 2009. The note was due on October 28, 2009 and carrying interest at 36% per year.		16,600		16,600
	Purchase order financing note issued in May 2010, carry interest at 24% per year and due on demand. The note was purchased by another debt holder and converted into common stock.		-		100,000
	Four promissory notes were issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The notes are convertible into common shares at a rate of $0.08/share. The notes bear interest at 10% per year and mature on March 31, 2015.		1,425,522		1,425,522
	Eight promissory notes issued to accredited investors in May through August 2013, maturing six to nine months after issuance. The notes carry interest at the rate of 15% per year. In May 2014 some of the notes were purchased by another debt holder, the balance was rolled into a new note for $1,250,000.		-		2,104,584
	Four promissory notes issued to accredited investors in July 2013, maturing seven months after issuance. The notes carry interest at the rate of 12% per year. In May 2014 some of the notes were purchased by another debt holder, the balance was rolled into a new note for $1,250,000.		-		589,544
	One promissory note issued to accreditied investor in May 2014, maturing January 23, 2015. The note carry interest at the rate of 12% per year.		1,250,000		-
	Six promissory notes issued to accredited investors in March, April and June 2014 maturing six months after issuance. The notes carry interest at the rate of 12% per year.		300,030		-
	One promissory note issued to accredited investor in May 2014, maturing February 23, 2015. The note carries interest at the rate of 12% per year.		510,000		-
	One promissory note issued to accredited investor in June 2014, maturing March 3, 2015. The note carries interest at the rate of 12% per year.		200,000		-
	Two promissory notes issued to accredited investor in September 2014, maturing in October 2014 and April 2015. The note carries interest at the rate of 12% per year.		126,923		-
	Total debt to affiliates		3,829,075		4,269,250
	Less short-term portion due to affiliates		3,829,075		2,843,728
	Total Long-Term Debt to affiliates	$	-	$	1,425,522
Schedule of Maturities of Long-term Debt	The following is a schedule of future minimum debt payments as of December 31, 2014:
	Year Ending December 31,
	2015	$	3,829,075
	Total minimum payments required	$	3,829,075

INCOME_TAX_Tables

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation of the effective income tax rate to the Federal statutory rate is as follows:
		2014		2013
	Federal Income Tax Rate	-34	%	-34	%
	State Income Tax, Net of Federal Benefit	-5.94	%	-5.94	%
	Change in valuation allowance	39.94	%	39.94	%
	Sale of New Jersey NOL	-4.4	%	-46	%
	Effective Income Tax Rate	-4.4	%	-46	%
Schedule of Deferred Tax Assets and Liabilities	Significant components of the Company's deferred tax assets and liabilities are summarized as follows:
		December 31,
		2014			2013
	Deferred tax assets		26,899,000			23,165,000
	Less: Valuation Allowance		-26,899,000			-23,165,000
	Net Deferred Tax Assets	$	-		$	-

CAPITAL_STOCK_Tables

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2014
Stockholders Equity Note [Abstract]
Schedule of Capital Units	Other information is summarized as follows:
		Convertible		Cumulative
		Series B		Series C
	Number of common shares to be issued upon conversion of each preferred share		10		None
	Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$	2	$	10	-1
	(1) Plus any dividend in arrears.

OPTIONS_AND_WARRANTS_Tables

OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Warrants Disclosure [Abstract]
Warrant Activity	Millennium had no options issued pursuant to this Plan as of December 31, 2014 and 2013, respectively.
			December 31, 2014					December 31, 2013
			Shares			Weighted		Shares		Weighted
						Average				Average
						Exercise				Exercise
						Price				Price
	Warrants outstanding - beginning of year			19,323,406		$	0.2		18,190,906	$	0.225
	Warrants exercised			-531,262			0.104		-		-
	Warrants granted			2,500,000			0.2		1,140,000		0.185
	Warrants expired			-			0		-7,500		60
	Warrants outstanding - end of year			21,292,144		$	0.223		19,323,406	$	0.2
	Warrants price range at end of year			$0.10 - $16.00					$0.10 - $16.00
	Warrants price for exercised shares			$0.00					$0.00
Schedule of fixed-price stock options and warrants outstanding	The following table summarizes information about fixed-price warrants outstanding
	Range of Exercise			Number			Average	Weighted		Number		Weighted
	Prices			Exercisable at			Remaining	Average		Exercisable at		Average
				December 31,			Contractual	Exercise Price		December 31,		Exercise Price
				2014			Life			2013
	$	0.1			7,500,000		35 Mo’s	$	0.1		7,500,000	$	0.1
	$	0.17			8,002,144		79 Mo’s	$	0.17		8,033,406	$	0.17
	$	0.2			6,227,500		25 Mo’s	$	0.2		3,727,500	$	0.2
	$	16			62,500		60 Mo’s	$	16		62,500	$	16
	$	60			-			$	60		-	$	60
					21,292,144						19,323,406

OPERATING_LEASE_LICENSE_AND_EM1

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2014
Operating Lease And License And Employment Commitments [Abstract]
Schedule of Future Minimum Lease Rental Payments	The following is a schedule of future minimum rental payments (exclusive of allocated expenses) required under operating leases that have initial or non-cancelable lease terms in excess of one year as of December 31, 2014:
	Year Ending December 31,
	2015		50,400
	2016		12,600
	Total minimum payments required	$	63,000
Schedule of Future Royalty Minimum Payment	Year Ending December 31,
	2015		2,100,000
	2016		2,700,000
	2017		3,200,000
	2018		3,800,000
		$	11,800,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Summary Of Significant Accounting Policies [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	240 months
Amortization of Intangible Assets	$1,576	$1,551
Advertising Expense	31,243	8,157
Shipping Cost	130,581	43,299
Handling Cost	112,005	44,467
Stock Issued During Period, Shares, Share-based Compensation, Forfeited	2,500,000	1,140,000
Stock Issued During Period, Value, Share-based Compensation, Forfeited	25,000	206,700
Tax credit carryforward, amount	375,645	3,357,144
Tax certificate transfer program fee	33,808	302,143
Unrecognized Tax Benefits Resulting in Net Operating Loss Carryforwards	$375,645	$3,357,144
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	8 years
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	3 years

Weighted_Average_Number_of_Sha

Weighted Average Number of Shares (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Potentially dilutive securities:
Convertible debt and accrued interest	390,211,843	10,751,345
Liability of shares to be issued	4,314,380	3,330,000
Convertible Preferred stock	154,555,045	49,713,545
Outstanding time-based warrants	21,292,144	19,323,406

GOING_CONCERN_Additional_Infor

GOING CONCERN - Additional Information (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Going Concern [Line Items]
Accumulated deficit	($92,855,018)	($84,737,002)

BUSINESS_ACQUISITION_Additiona

BUSINESS ACQUISITION - Additional Information (Detail) (USD $)	0 Months Ended	12 Months Ended
	Jan. 09, 2013	Dec. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross	$100,000	$0	$100,000
Finite-Lived Intangible Asset, Useful Life	5 years
Series G Preferred Stock
Business Acquisition [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	8,000
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$140,000

Valuation_of_Net_Assets_Acquir

Valuation of Net Assets Acquired (Detail) (USD $)	Dec. 31, 2014
Purchase Price Allocation [Line Items]
Goodwill	$135,000
Purchase Price	240,000
Trademarks
Purchase Price Allocation [Line Items]
Intangible assets	100,000
Customer Lists
Purchase Price Allocation [Line Items]
Intangible assets	$5,000

CONCENTRATIONS_OF_BUSINESS_AND1

CONCENTRATIONS OF BUSINESS AND CREDIT RISK - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Concentration Risk [Line Items]
Concentration Risk, Percentage	36.00%	55.00%
Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	19.00%	31.00%
Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	17.00%	13.00%
Customer Three [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		11.00%

Inventories_Detail

Inventories (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventory Disclosure [Line Items]
Finished Goods	$634,578	$378,472
Packaging	51,697	41,714
Inventory, gross, total	686,275	420,186
Less: Reserve for obsolescence	0	0
Total	$686,275	$420,186

Statement_of_Accounts_Payable_

Statement of Accounts Payable and Accrued Expenses (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Accounts Payable and Accrued Liabilities [Line Items]
Accounts payable	$3,067,081	$2,866,017
Accrued interest	833,215	1,016,584
Accrued rent expense	135,874	135,874
Accrued salaries, bonuses and payroll taxes	125,391	824,492
Accrued professional fees	218,593	230,433
Owed to officers	36,570	16,088
Accounts payable and accrued expenses	$4,416,724	$5,089,488

Fair_Value_Hierarchy_For_Finan

Fair Value Hierarchy For Financial Assets Measured at Fair Value on Recurring Basis (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	$910,590	$318,000
Total liabilities	910,590	318,000
Level I
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Total liabilities	0	0
Level II
Defined Benefit Plan Disclosure [Line Items]
Derivative liability
Total liabilities	0	0
Level III
Defined Benefit Plan Disclosure [Line Items]
Derivative liability	910,590	318,000
Total liabilities	$910,590	$318,000

Fair_Value_Liabilities_Measure

Fair Value Liabilities Measured on Recurring Basis Unobservable Input Reconciliation (Detail) (Derivative Liabilities [Member], USD $)	12 Months Ended
	Dec. 31, 2014
Derivative Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Balance at beginning of period	($318,000)
Issuance of notes with derivatives	-2,845,000
Derivative debt converted into equity	1,085,410
Gain on fair market valuation of derivatives	1,167,000
Balance at end of period	($910,590)

DEBT_Additional_Information_De

DEBT - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2014
Debt Instrument [Line Items]
Long-term Debt	$1,380,270	$2,462,528
Debt Instrument, Unamortized Discount	70,062	1,047,888
Debt Instrument, Fair Value Disclosure		1,096,487
Convertible Debt, Fair Value Disclosures		358,641
Debt Instrument, Convertible, Conversion Price		$0.20
Unit Notes [Member]
Debt Instrument [Line Items]
Notes Payable, Total	1,455,128
Promissory Note
Debt Instrument [Line Items]
Long-term Debt	4,269,250	3,829,075
Debt Instrument, Unamortized Discount	82,560	0
Promissory Note | Investor Group [Member]
Debt Instrument [Line Items]
Other Nonoperating Gains (Losses)	$358,641

Debt_Detail

Debt (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Short-term Debt [Line Items]
Total Debt	$2,462,528	$1,380,270
Less short-term portion	2,462,528	1,276,358
Long-term portion	0	103,912
8% Convertible Promissory Note Maturing In May 2004
Short-term Debt [Line Items]
Total Debt	30,000	30,000
12% One demand loans
Short-term Debt [Line Items]
Total Debt	0	10,000
10% Promisssory Note Maturing In November 30, 2006 and January 31, 2007
Short-term Debt [Line Items]
Total Debt	48,000	48,000
10% Promisssory Note Maturing In January 2007
Short-term Debt [Line Items]
Total Debt	44,000	44,000
10% Promisssory Note Maturing In March 2007
Short-term Debt [Line Items]
Total Debt	75,000	75,000
10% Promisssory Note Maturing In September 30, 2007
Short-term Debt [Line Items]
Total Debt	25,000	25,000
10% Promisssory Note due on July 31, 2008
Short-term Debt [Line Items]
Total Debt	400,000	400,000
2% Promissory Note Issued In November
Short-term Debt [Line Items]
Total Debt	0	85,726
10% Senior Secured Convertible Notes In September 2011
Short-term Debt [Line Items]
Total Debt	29,606	29,606
10% Promissory notes Issued In March and April 2012
Short-term Debt [Line Items]
Total Debt	70,139	74,306
15% Promissory Note Issued In March 2013
Short-term Debt [Line Items]
Total Debt	112,288	97,924
15% Promissory Note Issued In April, May and June 2013
Short-term Debt [Line Items]
Total Debt	0	191,551
15% Promissory Notes Issuance One In May 2013
Short-term Debt [Line Items]
Total Debt	0	96,012
15% Promissory Note Issuance Two In May 2013
Short-term Debt [Line Items]
Total Debt	0	95,948
10% Promissory Notes Re Issuance In August 2013
Short-term Debt [Line Items]
Total Debt	0	53,000
15% Promissory Notes Issuance In August 2013
Short-term Debt [Line Items]
Total Debt	26,521	24,197
15% Promissory notes Issued In March and April 2014
Short-term Debt [Line Items]
Total Debt	269,368	0
12% Promissory notes Issued In May 2014
Short-term Debt [Line Items]
Total Debt	439,052	0
12% Promissory notes Issued In July 2014
Short-term Debt [Line Items]
Total Debt	507,425	0
12% Promissory Note Issuance One In October 2014
Short-term Debt [Line Items]
Total Debt	19,863	0
4% Promissory notes Issued In October 2014
Short-term Debt [Line Items]
Total Debt	40,685	0
12% Promissory Note Issuance Two In October 2014
Short-term Debt [Line Items]
Total Debt	65,526	0
12% Promissory Note Issuance Three In October 2014
Short-term Debt [Line Items]
Total Debt	35,055	0
24% Promissory notes Issued In December 2014
Short-term Debt [Line Items]
Total Debt	$225,000	$0

Debt_Parenthetical_Detail

Debt (Parenthetical) (Detail) (USD $)	1 Months Ended	12 Months Ended
	Apr. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Debt Parenthetical [Line Items]
Debt Instrument, Convertible, Conversion Price		$0.20
Debt Conversion, Converted Instrument, Amount		$53,460	$55,188
Debt Instrument, Face Amount		379,000
Gains (Losses) on Extinguishment of Debt		-176,496	0
Debt Instrument, Periodic Payment	85,726
Debt Conversion, Converted Instrument, Shares Issued	750,000	61,081,644
Debt Conversion Converted Instrument Realized Gain	18,378
Series G Preferred Stock
Debt Parenthetical [Line Items]
Gains (Losses) on Extinguishment of Debt		46,978
8% Convertible Promissory Note Maturing In May 2004
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		20-May-04
Debt Instrument, Interest Rate During Period		8.00%
Debt Instrument, Convertible, Conversion Price		$20
12% One demand loans
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		12.00%
Debt Conversion, Converted Instrument, Amount		5,000
10% Promissory Note Maturing In November 30, 2006 and January 31, 2007
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument, Convertible, Conversion Price		$20
Debt Instrument Debt Default Interest Rate During Period		14.00%
10% Promissory Note Maturing In January 2007
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-07
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument, Convertible, Conversion Price		$20
Debt Instrument Debt Default Interest Rate During Period		20.00%
10% Promissory Note Maturing In March 2007
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Mar-07
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument, Convertible, Conversion Price		$20
Debt Instrument Debt Default Interest Rate During Period		14.00%
10% Promissory Note Maturing In September 2007
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		30-Sep-07
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument, Convertible, Conversion Price		$8
Debt Instrument Debt Default Interest Rate During Period		12.00%
Debt Instrument Accrued Interest Convertible Conversion Price		$8
10% Promissory Note due on July 31, 2008
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jul-08
Debt Instrument, Interest Rate During Period		10.00%
Debt Conversion, Converted Instrument, Amount		400,000
Debt Instrument, Face Amount		2,710,563
Repayments of Short-term Debt, Total		110,000
15% Promissory Note In November 2009
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		15.00%
Debt Interest Accrued Exchanged Into Promissory Note Units Rate		Units at the rate of 1:1
Promissory Note Units Per Value		$100,000
15% Promissory Note In November 2009 | Series F Preferred Stock
Debt Parenthetical [Line Items]
Debt Instrument Debt Default Stock Issued		100
Convertible Preferred Stock, Shares Issued upon Conversion		120,000
15% Promissory Note In November 2009 | Series G Preferred Stock
Debt Parenthetical [Line Items]
Debt Instrument, Convertible, Conversion Price		$73.50
Debt Conversion, Converted Instrument, Amount		2,044
Debt Instrument, Face Amount		67,021
Contingent Debt Instrument Convertible Conversion Price Description		Reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder's Unit Note in the Series G Preferred equity offering.
10% Promissory Note In September 2011
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Mar-15
Debt Instrument, Interest Rate During Period		10.00%
Financing Agreement Dated		14-Jul-11
10% Promissory Note In March and April 2012
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-13
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument, Convertible, Conversion Price		$0.20
Debt Conversion, Converted Instrument, Amount		25,000
Debt Instrument Accrued Interest Convertible Conversion Price		$0.20
Debt Instrument, Face Amount		$50,000
15% Promissory Note In March 2013
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		15.00%
Debt Instrument, Convertible, Conversion Price		$0.25
15% Promissory Note In April, May and June 2013
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-14
Debt Instrument, Interest Rate During Period		15.00%
15% Promissory Note In May 2013, maturing ten months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		15.00%
Debt Instrument, Convertible, Conversion Price		$0.20
15% Promissory Note In May 2013, maturing nine months
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		28-Feb-14
Debt Instrument, Interest Rate During Period		15.00%
15% Promissory Note In August 2013 maturing six months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		15.00%
10% Promissory Note In August 2013 maturing seven months
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-14
Debt Instrument, Interest Rate During Period		10.00%
Debt Instrument Debt Default Interest Rate During Period		15.00%
15% Promissory Note In March and April 2014 maturing eighteen months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		15.00%
12% Promisory Note In May 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		12.00%
Debt Conversion, Converted Instrument, Rate		62.00%
12% Promissory Note In July 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		12.00%
Debt Conversion, Converted Instrument, Rate		62.00%
12% Promissory Note one in October 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		12.00%
Debt Conversion, Converted Instrument, Rate		62.00%
4% Promissory Note In October 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Instrument, Interest Rate During Period		4.00%
Debt Conversion, Converted Instrument, Rate		55.00%
12% Promissory Note two in October 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Conversion, Converted Instrument, Rate		62.00%
12% Promissory Note three in October 2014 maturing twelve months
Debt Parenthetical [Line Items]
Debt Conversion, Converted Instrument, Rate		55.00%
24 Promissory Note In December 2014
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-15
Debt Instrument, Interest Rate During Period		24.00%
Maximum | 10% Promissory Note Maturing In November 30, 2006 and January 31, 2007
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		31-Jan-07
Minimum | 10% Promissory Note Maturing In November 30, 2006 and January 31, 2007
Debt Parenthetical [Line Items]
Debt Instrument, Maturity Date		30-Nov-06

Debt_to_Affiliates_Detail

Debt to Affiliates (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Short-term Debt [Line Items]
Total debt to affiliates	$3,829,075	$4,269,250
Short-term debt to affiliates, net of unamortized debt discount	3,829,075	2,843,728
Total Long-Term Debt to affiliates	0	1,425,522
15% Eight Promissory Note
Short-term Debt [Line Items]
Total debt to affiliates	0	2,104,584
12% Four Promissory Note
Short-term Debt [Line Items]
Total debt to affiliates	0	589,544
24% Promisssory Note Maturing In September 2009
Short-term Debt [Line Items]
Total debt to affiliates	0	33,000
36% Percent Promissory Note Maturing In October 2009
Short-term Debt [Line Items]
Total debt to affiliates	16,600	16,600
24% Demand Note
Short-term Debt [Line Items]
Total debt to affiliates	0	100,000
12% promissory note maturing in January 2015
Short-term Debt [Line Items]
Total debt to affiliates	1,250,000	0
12% promissory note maturing six month after issuance
Short-term Debt [Line Items]
Total debt to affiliates	300,030	0
12% promissory note maturing in February 2015
Short-term Debt [Line Items]
Total debt to affiliates	510,000	0
12% promissory note maturing in March 2015
Short-term Debt [Line Items]
Total debt to affiliates	200,000	0
12% promissory note maturing in October 2014 and April 2015
Short-term Debt [Line Items]
Total debt to affiliates	126,923	0
Affiliates [Member]
Short-term Debt [Line Items]
Total debt to affiliates	$1,425,522	$1,425,522

Debt_to_Affiliates_Parenthetic

Debt to Affiliates (Parenthetical) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
24% Promissory Note Maturing In September 2009
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	26-Sep-09
Debt instrument interest rate	24.00%
36% Percent Promissory Note October 2009
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	28-Oct-09
Debt instrument interest rate	36.00%
24% Demand Note May 2010
Debt Instrument [Line Items]
Debt instrument interest rate	24.00%
10% Promissiory Note Maturing In March 2015
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	31-Mar-15
Debt instrument interest rate	10.00%
Debt Instrument Accured Interest Convertible Conversion Price	0.08
15% Promissory Notes In August 2013 maturing six to nine months
Debt Instrument [Line Items]
Debt instrument interest rate	15.00%
Debt Instrument Value	1,250,000
12% Promissory Notes In July 2013 maturing seven months
Debt Instrument [Line Items]
Debt instrument interest rate	12.00%
Debt Instrument Value	1,250,000
12% Promissory Note In January 2015
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	23-Jan-15
Debt instrument interest rate	12.00%
12% Promissory Notes IN March, April, and June 2014 maturing after six months
Debt Instrument [Line Items]
Debt instrument interest rate	12.00%
12% Promissory Notes in Febuary 2015
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	23-Feb-15
Debt instrument interest rate	12.00%
12% Promissory Note In March 2015
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	3-Mar-15
Debt instrument interest rate	12.00%
12% Promissory Note in October 2014 and April 2015
Debt Instrument [Line Items]
Debt instrument interest rate	12.00%
12% Promissory Note in October 2014 and April 2015 | Maturity Date One
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	31-Oct-14
12% Promissory Note in October 2014 and April 2015 | Maturity Date Two
Debt Instrument [Line Items]
Debt Instrument, Maturity Date	30-Apr-15

Future_Minimum_Debt_Payments_D

Future Minimum Debt Payments (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
Year Ending December 31,
2015	$3,829,075
Total minimum payments required	$3,829,075

INCOME_TAX_Additional_informat

INCOME TAX - Additional information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Line Items]
Operating Loss carryforwards	$65,000,000
Operating Loss Carryforward Expiration Date	Net operating loss carry forwards expire starting in 2024 through 2032
Valuation allowance, deferred tax asset, change in amount	3,734,000
Deferred Tax Asset Valuation Allowance	$26,899,000

Reconciliation_of_Effective_In

Reconciliation of Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Schedule Of Effective Income Tax Rate Reconciliation [Line Items]
Federal Income Tax Rate	-34.00%	-34.00%
State Income Tax, Net of Federal Benefit	-5.94%	-5.94%
Change in valuation allowance	39.94%	39.94%
Sale of New Jersey NOL	-4.40%	-46.00%
Effective Income Tax Rate	-4.40%	-46.00%

Deferred_Tax_Assets_and_Liabil

Deferred Tax Assets and Liabilities (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Schedule Of Deferred Tax Assets And Liabilities [Line Items]
Deferred tax assets	$26,899,000	$23,165,000
Less: Valuation Allowance	-26,899,000	-23,165,000
Net Deferred Tax Assets	$0	$0

CAPITAL_STOCK_Additional_Infor

CAPITAL STOCK - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Capital Stock [Line Items]
Common stock, shares authorized	2,000,000,000	2,000,000,000
Common stock, par value	$0.00	$0.00
Unrecognized compensation cost related to non-vested warrant	$0
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years
Common Stock [Member]
Capital Stock [Line Items]
Common stock, shares authorized	2,000,000,000
Common stock, par value	$0.00
Unrecognized compensation cost related to non-vested warrant	$43,125
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years
Series C Preferred Stock
Capital Stock [Line Items]
Preferred stock, dividend rate, per-dollar-amount	$0.65
Preferred stock, par value	$1	$1
Series G Preferred Stock
Capital Stock [Line Items]
Preferred stock, shares authorized	400,000
Preferred stock, par value	$1
Preferred stock conversion rate	625
Preferred stock stated value per share	$50
Preferred stock, dividend payment terms	The shares of G Preferred shall bear a 10% annual dividend, payable quarterly in kind based on the equivalent of 90% of the average of the last ten trading day closing price of the Common Stock prior to the dividend payment date

Temporary_Equity_Detail

Temporary Equity (Detail) (USD $)	Dec. 31, 2014
Convertible Series B
Temporary Equity [Line Items]
Number of common shares to be issued upon conversion of each preferred share	10
Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$2
Cumulative Series C
Temporary Equity [Line Items]
Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$10	[1]
[1]	Plus any dividend in arrears.

OPTIONS_AND_WARRANTS_Additiona

OPTIONS AND WARRANTS - Additional Information (Detail) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 29, 2000
Options And Warrants [Line Items]
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	$1,592,552	$457,500
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized	$0
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years
Individual Owns More Than 10% Voting Power
Options And Warrants [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			110.00%
Non-Qualified Stock Options
Options And Warrants [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			85.00%
2001 Stock Option Plan
Options And Warrants [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			500,000
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period			5 years

Warrant_Activity_Detail

Warrant Activity (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Class of Warrant or Right [Line Items]
Outstanding at Beginning, Shares	19,323,406	18,190,906
Warrants exercised, Shares	-531,262	0
Warrants granted, Shares	2,500,000	1,140,000
Warrants expired, Shares	0	-7,500
Outstanding at end, Shares	21,292,144	19,323,406
Weighted Average Exercise Price, Outstanding at Beginning	$0.20	$0.23
Warrants exercised, Weighted Average Exercise Price	$0.10	$0
Warrants granted, Weighted Average Exercise Price	$0.20	$0.19
Warrants expired, Weighted Average Exercise Price	$0	$60
Weighted Average Exercise Price, Outstanding and exercisable at end	$0.22	$0.20
Warrants exercise price range lower range limit	$0.10	$0.10
Warrants exercise price range upper range limit	$16	$16
Warrants price for exercised shares	$0	$0

Fixed_Price_Stock_Options_and_

Fixed Price Stock Options and Warrants Outstanding (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number Exercisable Shares	21,292,144	19,323,406
Exercise price zero point one zero
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Average Remaining Contractual Life	35 months
Number Exercisable Shares	7,500,000	7,500,000
Weighted Average Exercise Price	$0.10	$0.10
Exercise price zero point one seven
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Average Remaining Contractual Life	79 months
Number Exercisable Shares	8,002,144	8,033,406
Weighted Average Exercise Price	$0.17	$0.17
Exercise price zero point two zero
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Average Remaining Contractual Life	25 months
Number Exercisable Shares	6,227,500	3,727,500
Weighted Average Exercise Price	$0.20	$0.20
Exercise price sixteen point zero
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Average Remaining Contractual Life	60 months
Number Exercisable Shares	62,500	62,500
Weighted Average Exercise Price	$16	$16
Exercise price sixty point zero
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number Exercisable Shares	0	0
Weighted Average Exercise Price	$60	$60

OPERATING_LEASE_LICENSE_AND_EM2

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Jul. 14, 2011
Leases, Operating [Line Items]
Operating leases, rent expense	$50,400	$47,282
Minimum royalty payments total	11,800,000
Royalty Payments Description	In the year ended December 31, 2014, $1,350,000 has been paid for the year ending December 31, 2014 with a remaining balance from 2014 of $450,000 nor payment due January 1, 2015 in the amount of $525,000 or the payment due April 1, 2015 in the amount of $525,000.
License Agreement
Leases, Operating [Line Items]
Minimum royalty payments total	13,600,000
Mr. James
Leases, Operating [Line Items]
Revised annual salary, current			150,000
Revised annual salary, after three fiscal quarters			200,000
Bonus payable after three fiscal quarters			$25,000

Future_Minimum_Lease_Rental_Pa

Future Minimum Lease Rental Payments (Detail) (USD $)	Dec. 31, 2014
Future Minimum Lease Rental Payments [Line Items]
2015	$50,400
2016	12,600
Total minimum payments required	$63,000

Future_Royalty_Minimum_Payment

Future Royalty Minimum Payment (Detail) (USD $)	Dec. 31, 2014
Future Royalty Minimum Payment [Line Items]
2015	$2,100,000
2016	2,700,000
2017	3,200,000
2018	3,800,000
Future minimum royalty payments due	$11,800,000

STOCK_GRANTED_FOR_SERVICES_AND1

STOCK GRANTED FOR SERVICES AND FINANCING - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Based Compensation Disclosure [Line Items]
Issuance of common for services	$636,388	$324,270
Common Stock
Stock Based Compensation Disclosure [Line Items]
Issuance of common stock for services (in shares)	3,767,500	1,637,500
Issuance of common for services	3,768	1,637
Stock Issued During Period, Value, Share-based Compensation, Gross	1,479,972
Stock Issued During Period, Shares, Share-based Compensation, Gross	6,627,069
Service | Common Stock
Stock Based Compensation Disclosure [Line Items]
Issuance of common stock for services (in shares)	3,767,500
Issuance of common for services	$334,238

RELATED_PARTY_TRANSACTIONS_Add

RELATED PARTY TRANSACTIONS - Additional Information (Detail) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
Related Party Transaction [Line Items]
Common stock, issued	143,301,039	62,461,448
Common Stock, Value, Issued	$143,301	$62,462
Mr. James
Related Party Transaction [Line Items]
Common stock, issued			2,000,000
Common Stock, Value, Issued			550,000
Mr. DeLucia
Related Party Transaction [Line Items]
Common stock, issued			500,000
Common Stock, Value, Issued			140,000
Mr. Kras
Related Party Transaction [Line Items]
Common stock, issued			2,000,000
Common Stock, Value, Issued			$550,000

LITIGATION_Additional_Informat

LITIGATION - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2014
Robert Half International
Litigation Settlements [Line Items]
Malpractice loss contingency, settlement of claims	$18,507
Creative Healthcare Solutions, LLC
Litigation Settlements [Line Items]
Percentage of materials destroy and dispose	80.00%
Loss Contingency, Damages Sought, Value	$63,718

SUBSEQUENT_EVENTS_Additional_I

SUBSEQUENT EVENTS - Additional Information (Detail) (USD $)	1 Months Ended	12 Months Ended		1 Months Ended
	Apr. 30, 2014	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Feb. 28, 2015	Jan. 16, 2015	Mar. 30, 2015
Subsequent Event [Line Items]
Receivable From Technology Business Tax Certificate Transfer Program		$375,645	$3,357,144
Tax Certificate Transfer Program Fee		33,808	302,143
Net Tax Credit Carryforward Amount		341,837
Debt Instrument, Face Amount		379,000
Debt Instrument, Increase, Accrued Interest		1,775
Debt Conversion, Converted Instrument, Shares Issued	750,000	61,081,644
Subsequent Event
Subsequent Event [Line Items]
Receivable From Technology Business Tax Certificate Transfer Program						375,645
Subsequent Event | Convertible Debt
Subsequent Event [Line Items]
Debt Instrument, Face Amount					75,000		150,000
Debt Instrument, Interest Rate, Stated Percentage					9.09%		12.00%
Debt Conversion, Description				The debt is convertible into common stock at 62% of the lowest trading price on the prior 10 trading days.	The debt is convertible into common stock at 55% of the lowest closing price based on the prior 15 trading days.
Debt Instrument, Term				1 year	1 year
Subsequent Event | Four Percent Interest Rate | Convertible Debt
Subsequent Event [Line Items]
Debt Instrument, Face Amount							$110,000
Debt Instrument, Interest Rate, Stated Percentage							4.00%
Debt Conversion, Description				The debt is convertible into common stock at 55% of the lowest trading price on the prior 15 trading days.
Debt Instrument, Term				1 year